» Articles » PMID: 1987060

Immunological Characterization of Clostridium Butyricum Neurotoxin and Its Trypsin-induced Fragment by Use of Monoclonal Antibodies Against Clostridium Botulinum Type E Neurotoxin

Overview
Journal Infect Immun
Date 1991 Jan 1
PMID 1987060
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the reactivities of Clostridium butyricum neurotoxin to nine monoclonal antibodies against Clostridium botulinum type E neurotoxin which recognize the light chain or the amino-terminal half (H-1 fragment) or the carboxyl-terminal half (H-2 fragment) of the heavy chain of botulinum neurotoxin. Butyricum neurotoxin and its derived chains did not react to two of four monoclonal antibodies recognizing the light chain, one of three recognizing the H-1 fragment, and one of two recognizing the H-2 fragment. The results indicate that the immunological difference between the two neurotoxins is not attributable to a particular portion of the toxin molecule. The fragment of butyricum neurotoxin obtained by prolonged tryptic treatment was found to comprise the light chain and H-1 fragment linked together by a disulfide bond.

Citing Articles

Effects of Megaplasmid Loss on Growth of Neurotoxigenic Clostridium butyricum Strains and Botulinum Neurotoxin Type E Expression.

Scalfaro C, Iacobino A, Grande L, Morabito S, Franciosa G Front Microbiol. 2016; 7:217.

PMID: 26941734 PMC: 4766289. DOI: 10.3389/fmicb.2016.00217.


Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.

Conway J, Sherwood L, Collazo M, Garza J, Hayhurst A PLoS One. 2010; 5(1):e8818.

PMID: 20098614 PMC: 2809108. DOI: 10.1371/journal.pone.0008818.


Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in japan.

Kozaki S, Kamata Y, Nishiki T, Kakinuma H, Maruyama H, Takahashi H Infect Immun. 1998; 66(10):4811-6.

PMID: 9746583 PMC: 108594. DOI: 10.1128/IAI.66.10.4811-4816.1998.


Characterization of a neurotoxigenic Clostridium butyricum strain isolated from the food implicated in an outbreak of food-borne type E botulism.

Meng X, Karasawa T, Zou K, Kuang X, Wang X, Lu C J Clin Microbiol. 1997; 35(8):2160-2.

PMID: 9230405 PMC: 229926. DOI: 10.1128/jcm.35.8.2160-2162.1997.


Evaluation of a rapid air thermal cycler for detection of Mycobacterium tuberculosis.

Chapin K, Lauderdale T J Clin Microbiol. 1997; 35(8):2157-9.

PMID: 9230404 PMC: 229925. DOI: 10.1128/jcm.35.8.2157-2159.1997.


References
1.
MIDURA T, Arnon S . Infant botulism. Identification of Clostridium botulinum and its toxins in faeces. Lancet. 1976; 2(7992):934-6. DOI: 10.1016/s0140-6736(76)90894-1. View

2.
McCroskey L, Hatheway C, Fenicia L, Pasolini B, Aureli P . Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. J Clin Microbiol. 1986; 23(1):201-2. PMC: 268605. DOI: 10.1128/jcm.23.1.201-202.1986. View

3.
Kozaki S, Kamata Y, Nagai T, Ogasawara J, Sakaguchi G . The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin. Infect Immun. 1986; 52(3):786-91. PMC: 260927. DOI: 10.1128/iai.52.3.786-791.1986. View

4.
Binz T, Kurazono H, Wille M, Frevert J, Wernars K, Niemann H . The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins. J Biol Chem. 1990; 265(16):9153-8. View

5.
Kozaki S, Ogasawara J, Shimote Y, Kamata Y, Sakaguchi G . Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids. Infect Immun. 1987; 55(12):3051-6. PMC: 260027. DOI: 10.1128/iai.55.12.3051-3056.1987. View